Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
| Autor: | Wallace, Danielle S., Zent, Clive S., Baran, Andrea M., Reagan, Patrick M., Casulo, Carla, Rice, Geoffrey, Friedberg, Jonathan W., Barr, Paul M. |
|---|---|
| Zdroj: | In Blood Advances 13 June 2023 7(11):2496-2503 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|